Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
     
Biology of Reinforcement—Dopamine Linked to Three Separate Reward Paths

16 October 2007. Pavlov may not have known it, but his bell got more than saliva flowing. His experiments undoubtedly spurred dopamine release in his dogs’ brains, and probably in his own as well. We now know that the neurotransmitter mediates positive reinforcement associated with reward. More controversial is whether dopamine plays any role in negative reinforcement, as in learning to avoid displeasurable, or non-rewarding stimuli. A paper in the October 8 PNAS suggests that it does.

Researchers led by Michael Frank at the University of Arizona, Tucson, have correlated genetic polymorphisms with reward learning in young, healthy adults. Their findings indicate that dopamine plays a role in three independent reward pathways—short-term adaptability, and positive and negative long-term reinforcement. The findings are of interest to schizophrenia researchers given that compromised decision-making is one of the most debilitating facets of the disease.

Frank and colleagues studied the DARPP-32, DRD2, and COMT genes, all three linked to dopamine function: DRD2 is the gene for the D2 dopamine receptor; DARPP-32 codes for dopamine and cAMP regulated phosphoprotein of 32 kDa, which mediates the effects of dopamine D1 activation on synaptic plasticity; and COMT codes for catechol-O-methyl transferase, an enzyme that degrades dopamine. All three are candidate risk genes for schizophrenia (see SRF related news story and SRF news story).

The authors focused on an A/G DARPP-32 polymorphism that modulates striatal function (see SRF related news story). They predicted that this polymorphism might affect reward-based learning, since the DARPP-32 is highly abundant in the striatum, where D1 activation has been linked to decision-making based on positive outcomes. They focused on a C957T polymorphism in the DRD2 gene that affects post-synaptic D2 density, predicting that it might influence decisions associated with negative outcomes. And they looked at the Val158Met polymorphism in the COMT gene, which is associated with changes in dopamine level in the prefrontal cortex (see SRF related news story). The authors write that “this genetic marker of prefrontal DA function would predict the extent to which participants maintain negative outcomes in working memory to quickly adjust their behavior on a trial-to-trial basis.” The prefrontal cortex is an area of particular interest to schizophrenia researchers.

The authors correlated the three polymorphisms with reinforcement learning. Frank had healthy, young undergraduate students take part in a computerized test that simultaneously measures how well positive and negative feedback is learned. Briefly, the volunteers learn that on a probabilistic basis one possibility, “A,” is best chosen, while another, “B,” is best avoided.

The results supported the predictions. Averaging over a number of trials, DARPP-32 AA homozygotes were better than G carriers in the “choose-A” positive reinforcement scenario. In contrast, compared to those carrying the C allele, DRD2 TT homozygotes were much better in the “avoid-B” scenario, suggesting that they learn better from negative feedback. The Val/Met COMT polymorphism had no effect on positive reinforcement learning or avoidance learning over the long term. However, it did affect behavior on a trial-to-trial basis. Volunteers homozygous for the Val allele (and also the lowest prefrontal cortex dopamine) were less likely to alter their response based on a prior negative outcome.

“One of the surprising findings was that we saw such a large effect with individual genes,” said Frank in an interview with SRF. He noted that the results do not suggest 100 percent predictability; in other words, you cannot look at any one person’s genotype and know exactly how he or she is learning, “but nevertheless, across the samples the effect sizes we found were relatively large,” said Frank.

The other surprise was the D2 dopamine receptor role in negative reward learning, which has been a highly debated topic. Frank explained that work in primates has shown there is a pause in dopaminergic firing when the animals fail to get an expected reward. This has led to the suggestion that a dip in dopamine release may be involved in negative feedback learning. “The reason that is controversial is because the pause in these dopamine cells that happens during negative feedback is relatively small and because the baseline firing rate is already pretty low, so when they pause the change in firing rate is not nearly as big as during reward,” he explained. “In our specific model we can account for that because this negative-feedback learning depends on the D2 receptor, which is really sensitive to dopamine levels: essentially it is more sensitive to these small changes than the D1 receptor, which requires greater activation,” he said. He also stressed that this latest finding does not rule out the involvement of other neurotransmitters in avoidance learning.

Do these findings have any significance for schizophrenia research? The disease is certainly linked to dopamine dysfunction (see SRF Current Hypothesis) and also to deficits in the prefrontal cortex. Frank has already done a study in schizophrenic patients, in collaboration with Jim Gold’s lab at the University of Maryland, Baltimore. They found that people with schizophrenia were indeed impaired in that same measure of rapid learning from negative feedback, but they were just fine on long-term integration of negative feedback over many trials (see Waltz et al., 2007). But though the dopamine hypothesis for schizophrenia is a long-standing one, “there are many other factors that need to be considered in schizophrenia,” said Frank. “However, I do think that studying schizophrenia from a motivational standpoint, looking at reward processing, can be very fruitful. If there is a fundamental dysfunction in reward learning circuitry, that can lead to compounding effects on all sorts of behaviors," he said.—Tom Fagan.

Reference:
Frank MJ, Moustafa AA, Haughey HM, Curran T, Hutchison K. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. PNAS. 2007 Oct 8;104:16311-16316. Abstract

 
Comments on News and Primary Papers
Comment by:  Patricia Estani
Submitted 16 November 2007 Posted 16 November 2007
  I recommend the Primary Papers

Primary Papers: Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.

Comment by:  Phil Corlett
Submitted 29 November 2007 Posted 29 November 2007
  I recommend this paper

The earliest formulations of schizophrenia hypothesized that the formation of inappropriate associations between stimuli, thoughts, and percepts was a core disease process (Bleuler, 1911/1950; Schneider, 1930). Having developed an understanding of association formation both psychologically and physiologically in experimental animals, Pavlov attempted to apply what he had learned to psychiatric patients at the Balinskiy Psychiatric Hospital (Pavlov, 1928). This attempt is being realized through translational behavioral neuroscience studies of the role of dopaminergic neurotransmission in the midbrain, striatum, and prefrontal cortex in associative learning, implicating aberrant learning processes and their brain basis in the mesocorticolimbic dopamine system in the genesis of positive psychotic symptoms (Kapur , 2003) and in particular delusional beliefs (Corlett et al., 2006; Corlett et al., 2007;   Read more


View all comments by Phil Corlett
Comments on Related News
Related News: New Genetic Variations Link Schizophrenia and Bipolar Disorder

Comment by:  Mary Reid
Submitted 28 September 2006 Posted 29 September 2006

It's of interest that Vazza and colleagues suggest that 15q26 is a new susceptibility locus for schizophrenia and bipolar disorder. I have suggested that reduced function of the anti-inflammatory SEPS1 (selenoprotein S) at 15q26.3 may reproduce the neuropathology seen in schizophrenia.

View all comments by Mary Reid


Related News: New Genetic Variations Link Schizophrenia and Bipolar Disorder

Comment by:  Patricia Estani
Submitted 5 October 2006 Posted 6 October 2006
  I recommend the Primary Papers

Related News: The New "Inverted U”—Cellular Basis for Dopamine Response Pinpointed

Comment by:  Andreas Meyer-Lindenberg
Submitted 8 February 2007 Posted 8 February 2007

This fascinating paper contributes to our mechanistic understanding of a fundamental nonlinearity governing the response of prefrontal neurons during working memory to dopaminergic stimulation: the “inverted U” response curve (Goldman-Rakic et al., 2000), which proposes that an optimum range of dopaminergic stimulation exists, and that either too little or too much dopamine impairs tuning, or the relationship between task-relevant (“signal”) and task-irrelevant (“noise”) firing of these neurons. On the level of behavior, this is predicted to result in impaired working memory performance outside the optimum middle range, and this has been confirmed in a variety of species. This is a topic of high relevance for schizophrenia where prefrontal dysfunction and related cognitive deficits, and dopaminergic dysregulation, have long been in the center of research interest (Weinberger et al., 2001), and may be linked (  Read more


View all comments by Andreas Meyer-Lindenberg

Related News: DARPP-32 Haplotype Affects Frontostriatal Cognition and Schizophrenia Risk

Comment by:  Jonathan Burns
Submitted 14 February 2007 Posted 14 February 2007

This study provides hard empirical evidence for the hypothesis that psychosis (and schizophrenia in particular) represents a costly "byproduct" of complex human (social) brain evolution. Interestingly, the activation paradigms in the fMRI study (N-back and emotional face-matching tasks) are both testing social cognition. And the demonstrated changes in frontostriatal connectivity support the hypothesis that schizophrenia is a disorder of evolved intrahemispheric circuits comprising the Social Brain in our species.

I would suggest that further candidates (conferring vulnerability to psychosis) should be sought from amongst those genes known to have played a significant role in human brain evolution.

References:

Burns J. (2007) The Descent of Madness: Evolutionary Origins of Psychosis and the Social Brain. Routledge Press: Hove, Sussex.

Burns J. The social brain hypothesis of schizophrenia. World Psychiatry. 2006 Jun;5(2):77-81. Abstract

Burns JK. Psychosis: a costly by-product of social brain evolution in Homo sapiens. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):797-814. Epub 2006 Mar 3. Review. Abstract

Burns JK. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav Brain Sci. 2004 Dec;27(6):831-55; discussion 855-85. Review. Abstract

View all comments by Jonathan Burns


Related News: The New "Inverted U”—Cellular Basis for Dopamine Response Pinpointed

Comment by:  Terry Goldberg
Submitted 6 April 2007 Posted 6 April 2007

In this landmark study, Arnsten and colleagues used a full dopamine agonist in awake behaving monkeys to make key points about the inverted U response at the cellular level and how this maps to the behavioral level. There were a number of surprises. The first was that stimulation of the D1 receptor had consistently suppressive effects on neuronal firing during delays in a working memory task. The second was that when responses were optimized, suppressive effects differentially affected non-preferred directional neurons, rather than preferred direction neurons. Thus, it appeared that noise was reduced rather than signal amplified. Too much D1 stimulation resulted in suppression of both classes of neurons.

The implications of this work are important because it suggests that there is a neurobiological algorithm at work that can reliably produce this unexpected physiological pattern (perhaps as the authors suggest on the basis of baseline activity). It remains to be elucidated whether the D1 receptor effects are mediated by glutamatergic neurons or GABA interneurons, or both....  Read more


View all comments by Terry Goldberg

Related News: DARPP-32 Haplotype Affects Frontostriatal Cognition and Schizophrenia Risk

Comment by:  Daniel Durstewitz
Submitted 8 June 2007 Posted 8 June 2007
  I recommend the Primary Papers

The phosphoprotein DARPP-32 occupies a central position in the dopamine-regulated intracellular cascades of cortical and striatal neurons (Greengard et al., 1999). It is a point of convergence for multiple signaling pathways, is differentially affected by D1- vs. D2-class receptor activation, and mainly through inhibition of protein-phosphotase-1 mediates or contributes to a number of the dopaminergic effects on voltage- and ligand-gated ion channels. These, in turn, by regulating intracellular Ca2+ levels, themselves influence phosphorylation of DARPP-32 and thereby interact with dopamine-induced processes.

Given its central, vital role in dopamine-regulated signaling pathways, it is quite surprising that (to my knowledge) only a few studies exist on the implications of DARPP-32 variations for cognitive functions and brain activity. Therefore, this comprehensive series of studies by Meyer-Lindenberg et al. combining human genetics, structural and functional MRI, and behavioral testing represents an important milestone....  Read more


View all comments by Daniel Durstewitz

Related News: Does Toxoplasma Gondii Hijack the Dopamine Reward System of Rats?

Comment by:  Fuller TorreyRobert Yolken
Submitted 2 December 2008 Posted 2 December 2008

The research being carried out by Dr. Sapolsky and colleagues at Stanford is potentially very important for understanding schizophrenia. (In regard to full disclosure, it should be noted that the Stanley Medical Research Institute (SMRI) is funding Dr. Sapolsky’s research as well as other research on dopamine and Toxoplasma gondii.)

The origin of interest in dopamine and T. gondii appears to have been the 1985 paper by Henry H. Stibbs, then in the School of Public Health and Community Medicine at the University of Washington. Stibbs had been studying trypanosomes and sleeping sickness for 10 years and discovered that this organism increased dopamine levels by 34 percent in infected rats (Stibbs, 1984). He therefore turned his attention to T. gondii because of its known ability to alter learning, memory, and behavior in infected mice and rats. He infected 30 mice with the C56 strain of T. gondii. Ten mice were infected, became symptomatic, and were killed at 12 days (= acute group). Ten mice were...  Read more


View all comments by Fuller Torrey
View all comments by Robert Yolken

Related News: Does Toxoplasma Gondii Hijack the Dopamine Reward System of Rats?

Comment by:  Tamas Treuer
Submitted 9 December 2008 Posted 9 December 2008

Congratulations to Profs. Sapolsky, Torrey, and Yolken for their important contribution to this field. The question for me is rather an evolutionary one: is there any trace in the neuron-immuno-endocrine system of patients with schizophrenia that can reflect the adaptation to this hijacking attempt of this protozoon? Recent meta-analyses have provided a comprehensive overview of studies investigating Toxoplasma gondii antibodies in schizophrenic patients, thus attempting to clarify the potential role these infections might play in causing schizophrenia (Torrey and Yolken, 2007). Associations and theories that may enrich the current level of knowledge with regard to this significant subject deserve attention. Anti-parasitic agents as well as antipsychotics are effective in treating parasitosis. Both classes of drugs have been shown to exert dopaminergic activity. Parasites and human organisms have a long history of mutual contact. The effect of parasitosis on the host and the host's response to infection are undoubtedly the...  Read more


View all comments by Tamas Treuer

Related News: Does Toxoplasma Gondii Hijack the Dopamine Reward System of Rats?

Comment by:  Jaroslav Flegr
Submitted 9 December 2008 Posted 9 December 2008

The results of the research performed by Dr. Sapolsky and colleagues at Stanford, elaborating the results obtained by Drs. Berdoy and Webster at Oxford (Berdoy et al., 2000), are really fascinating. It should not be forgotten, however, that dopamine is not the only suspected molecule. There are several indirect and recently even direct indications for changed levels of testosterone in subjects with latent toxoplasmosis (Flegr et al., 2008). Moreover, the increased levels of dopamine in Toxoplasma infected mice and men seem to be byproducts of local brain inflammations, rather than a product of biologically important manipulation of the host behavior by the parasite. The results from human cytomegalovirus, i.e., the parasite transmitted by direct contact, not by predation, suggest that an infection of brain tissue by various parasites could increase the level of brain dopamine (Skallová et al., 2005). From the point of view of...  Read more


View all comments by Jaroslav Flegr

Related News: Does Toxoplasma Gondii Hijack the Dopamine Reward System of Rats?

Comment by:  Huan Ngo
Submitted 16 December 2008 Posted 16 December 2008

Drs. Sapolsky's and Vyas's recent body of data have provided significant mechanistic insights into the parasite manipulation hypothesis, the dopamine hypothesis of schizophrenia and the gene-environment etiological paradigm.

Since most of the human epidemiological data currently emphasizes Toxoplasma exposure from the prenatal period, do we know whether maternal infection results in dopamine alteration in the prenatal, neonatal or postnatal amydala? Is the effect caused directly by transplacental migration of the parasite to the prenatal amydala, or indirectly by maternal cytokine effects, such as IL6 or IL8, on the embryonic brain?

View all comments by Huan Ngo


Related News: Does Toxoplasma Gondii Hijack the Dopamine Reward System of Rats?

Comment by:  Artyom Tikhomirov
Submitted 18 December 2008 Posted 22 December 2008

It seems like both bacteria and protozoa have been shown to either increase or decrease certain defensin levels in humans (Sperandio et al., 2008; Wiesenfeld et al., 2002). Then there's a single report from Sabine Bahn's group of increased α-defensins in schizophrenia (Craddock et al., 2008). It is interesting to speculate whether Toxoplasma gondii might contribute to the change in defensin levels.

References:

Sperandio B, Regnault B, Guo J, Zhang Z, Stanley SL, Sansonetti PJ, Pédron T. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med. 2008 May 12;205(5):1121-32. Abstract

Craddock RM, Huang JT, Jackson E, Harris N, Torrey EF, Herberth M, Bahn S. Increased alpha-defensins as a blood marker for schizophrenia susceptibility. Mol Cell Proteomics. 2008 Jul 1;7(7):1204-13. Abstract

Wiesenfeld HC, Heine RP, Krohn MA, Hillier SL, Amortegui AA, Nicolazzo M, Sweet RL. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis. 2002 Sep 15;186(6):792-7. Abstract

View all comments by Artyom Tikhomirov


Related News: Cognition and Dopamine—D1 Receptors a Damper on Working Memory?

Comment by:  Michael J. Frank
Submitted 19 February 2009 Posted 19 February 2009

McNab and colleagues provide groundbreaking evidence showing that cognitive training with working memory tasks over a five-week period impacts D1 dopamine receptor availability in prefrontal cortex. Links between prefrontal D1 receptor function and working memory are often thought to be one-directional, i.e., that better D1 function supports better working memory, but here the authors show that working memory practice reciprocally affects D1 receptors.

An influential body of empirical and theoretical research suggests that an optimal level of prefrontal D1 receptor stimulation is required for working memory function (e.g., Seemans and Yang, 2004). Because acute pharmacological targeting of prefrontal D1 receptors reliably alters working memory, causal directionality from D1 to working memory remains evident. Nevertheless, these findings cast several other studies in a new light. Namely, when a population exhibits impaired (or enhanced) working memory and PET studies indicate differences in dopaminergic function, it is no longer...  Read more


View all comments by Michael J. Frank

Related News: Cognition and Dopamine—D1 Receptors a Damper on Working Memory?

Comment by:  Terry Goldberg
Submitted 3 March 2009 Posted 3 March 2009

This is an important article that describes profound changes in the dopamine D1 receptor binding potential after working memory training in healthy male controls. The study rests on prior work that has demonstrated changes in brain volume with practice (e.g., Draganski and May, 2008), and dopamine can be released at the synapse in measurable amounts even during, dare I say, fairly trivial activities (e.g., playing a video game (Koepp et al., 1998). The present study demonstrated that binding potential of D1 receptors decreased in cortical regions (right ventrolateral frontal, right dorsolateral PFC, and posterior cortices) with training, and the magnitude of this decrease correlated with the improvement during training. Binding potential of D2 receptors in the striatum did not change. Unfortunately, D2 receptors in the cortex could not be measured with raclopride.

Two points come to mind. One is theoretical—how long would such a change remain, i.e., is it transient or is it...  Read more


View all comments by Terry Goldberg
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Copyright © 2005- 2013 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright